Prof. Panagiotis Georgoulias

University of Thessaly, Greece

Email: pgeorgoul@med.uth.gr

Qualifications

1998 Ph.D., University of Crete in Heraklion, Greece

1991 M.D., National & Kapodistrian University in Athens, Greece

Publications (Selected)

1. Angelidis G, Giamouzis G, Karagiannis G, Butler J, Tsougos I, Valotassiou V, Giannakoulas G, Dimakopoulos N, Xanthopoulos A, Skoularigis J, Triposkiadis F, Georgoulias P. SPECT and PET in ischemic heart failure. Heart Fail Rev. 2017 Feb 2.
2. Alexiou S, Georgoulias P, Angelidis G, Valotassiou V, Tsougos I, Psimadas D, Lakiotis V, Kaspiri A, Alexopoulos D, Apostolopoulos D, Vassilakos P. Myocardial perfusion and left ventricular quantitative parameters obtained using gated myocardial SPECT: Comparison of three software packages. J Nucl Cardiol. 2016 Nov 21.
3. Karayannis G, Triposkiadis F, Skoularigis J, Georgoulias P, Butler J, Giamouzis G. The emerging role of galectin-3 and ST2 in heart failure: Practical considerations and pitfalls using novel biomarkers. Curr Heart Fail Rep. 2013;10:441-449.
4. Karayannis G, Giamouzis G, Tziolas N, Georgoulias, P, Skoularigis J, Mikhailidis DP, Triposkiadis F. Association between epicardial fat thickness and weight homeostasis hormones in patients with noncachectic heart failure. Angiology 2013;64:173-180.
5. Mastrogiannis D, Giamouzis G, Dardiotis E, Karayannis G, Chroub-Papavaiou A, Kremeti D, Spiliopoulos K, Georgoulias P, Koutsias S, Bonotis K, Mantzorou M, Skoularigis J, Hadjigeorgiou GM, Butler J, Triposkiadis F. Depression in patients with cardiovascular disease. Cardiol Res Pract. 2012;1:794762.
6. Georgoulias P, Tsougos I, Tzavara C, Valotassiou V, Demakopoulos N. Incremental prognostic value of 99mTc-tetrofosmin early poststress pulmonary uptake. Determination of the optimal cut-off value. Nucl Med Commun. 2012;33:470-475.
7. Tsarouhas K, Tsitsimpikou C, Haliassos A, Georgoulias P, Koutsioras I, Kouretas D, Kogias J, Liosis I, Rentoukas E, Kyriakides Z. Study of insulin resistance, TNF-α, total antioxidant capacity and lipid profile in patients with chronic heart failure under exercise. In Vivo. 2011;25:1031-1037.
8. Georgoulias P, Tsougos I, Valotassiou V, Demakopoulos N. Does hybrid diagnostic imaging in cardiology have the same significance as in oncology? Eur J Nucl Med Mol Imaging. 2011;38:979-981.
9. Satra M, Samara M, Wosniak G, Tzavara C, Kontos A, Valotassiou V, Vamvakopoulos NK, Tsougos I, Aleporou-Marinou V, Patrinos GP, Kollia P, Georgoulias P. Sequence variations in the FII, FV, F13A1, FGB and PAI-1 genes are associated with differences in myocardial perfusion. Pharmacogenomics. 2011;12:195-203.
10. Georgoulias P, Valotassiou V, Tsougos I, Demakopoulos N. Myocardial perfusion SPECT imaging in patients after percutaneous coronary intervention. Curr Cardiol Rev. 2010;6:98-103.
11. Georgoulias P, Tsougos I, Valotassiou V, Samara M, Kollia P. Darwinian molecular imaging in nuclear cardiology. Eur J Nucl Med Mol Imaging. 2010;37:829-830.
12. Georgoulias P, Tsougos I, Valotassiou V, Tzavara C, Xaplanteris P, Demakopoulos N. Long-term prognostic value of early poststress 99mTc-tetrofosmin lung uptake during exercise (SPECT) myocardial perfusion imaging. Eur J Nucl Med Mol Imaging. 2010;37: 789-798.
13. Georgoulias P, Wozniak G, Samara M, Chiotoglou I, Kontos A, Tzavara C, Valotassiou V, Georgitsi M, Aleporou-Marinou V, Patrinos GP, Kollia P. Impact of ACE and ApoE polymorphisms on myocardial perfusion: Correlation with myocardial single photon emission computed tomographic imaging. J Hum Genet. 2009;54:595-602.
14. Georgoulias P, Demakopoulos N, Valotassiou V, Orfanakis A, Zaganides A, Tsougos I, Fezoulidis I. Long-term prognostic value of heart-rate recovery after treadmill testing in patients with diabetes mellitus. Int J Cardiol. 2009;134:67-74.
15. Georgoulias P, Valotassiou V, Tsougos I. Heart-rate recovery as a clinical marker of cardiovascular autonomic dysfunction in diabetic patients. Eur J Nucl Med Mol Imaging. 2009;36:320-321.
16. Georgoulias P, Valotassiou V, Tsougos I. Drug enhancement of myocardial tracer uptake during myocardial perfusion imaging. Eur J Nucl Med Mol Imaging. 2009;36:160-161.
17. Georgoulias P, Tzavara C, Demakopoulos N, Giannakou S, Valotassiou V, Tsougos I, Xaplanteris P, Fezoulidis I. Incremental prognostic value of 99mTc-tetrofosmin myocardial SPECT after percutaneous coronary intervention. Ann Nucl Med. 2008;22:899-909.
18. Georgoulias P, Demakopoulos N, Tzavara C, Giannakou S, Valotassiou V, Tsougos I, Xaplanteris P, Fezoulidis I. Long-term prognostic value of Tc-99m tetrofosmin myocardial gated-SPECT imaging in asymptomatic patients after percutaneous coronary intervention. Clin Nucl Med. 2008;33:743-747.
19. Georgoulias P, Valotassiou V, Wozniak G, Demakopoulos N, Fezoulidis I. Myocardial perfusion SPECT imaging in patients after coronary revascularization. Vascular Disease Prevention. 2008;5:9-16.
20. Georgoulias P, Demakopoulos N, Orfanakis A, Xydis K, Xaplanteris P, Vardas P, Fezoulidis I. Evaluation of abnormal heart-rate recovery after exercise testing in patients with diabetes mellitus: Correlation with myocardial SPECT and chronotropic parameters. Nucl Med Commun. 2007;28:165-171.